Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: Correlation with ERBB-2 protein expression and ERBB2 gene copy number

Pathology Research and Practice

Volumn 199, Issue 7, 2003, Pages 453-461

  Mrhalová, Marcela ^a   Kodet, Roman ^a   Kalinová, Markéta ^a   Hilská, Irena ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Breast carcinoma; ERBB2; mRNA; Quantification

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; TRASTUZUMAB;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE NUMBER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; PROTEIN EXPRESSION; PROTO ONCOGENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0042882658     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00445     Document Type: Article

References (34)

1. Bankfalvi A, Simon R, Brandt B, Burger H, Vollmer I, Dockhorn-Dworniczak B, Lelle RJ, Boecker W (2000) Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use. Histopathology 37: 411-419
2. Bartlett JM, Going JJ, Mallon EA, Watters AD, Reeves JR, Stanton P, Richmond J, Donald B, Ferrier R, Cooke TG (2001) Evaluating HER2 amplification and overexpression in breast cancer. J Pathol 195: 422-428
3. Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, Vidaud M (1999) Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 45: 1148-1156
4. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139
5. Couturier J, Vincent-Salomon A, Nicolas A, Beuzeboc P, Mouret E, Zafrani B, Sastre-Garau X (2000) Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma. Mod Pathol 13: 1238-1243
6. de Lange MS, Top B, Lambrechts C, Maas RA, Peterse HL, Mooi WJ, van't Veer LJ, Rodenhuis S (1997) A method to monitor mRNA levels in human breast tumor cells obtained by fine-needle aspiration. Diagn Mol Pathol 6: 353-360
7. Elston CW, Ellis IO (1998, reprinted 1999) Assessment of histological grade. In: Elston CW, Ellis IO (Eds) The Breast, 3rd ed., pp 365-384. Churchill Livingstone, Edinburgh
8. Hoang MP, Sahin AA, Ordonez NG, Sneige N (2000) HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. Am J Clin Pathol 113: 852-859
9. Hung MC, Lau YK (1999) Basic science of HER-2/neu: a review. Semin Oncol 26: 51-59
10. Hynes NE, Stern DF (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198: 165-184
11. Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR (1990) Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res 50: 6701-6707
12. Jimenez RE, Wallis T, Tabasczka P, Visscher DW (2000) Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization. Mod Pathol 13: 37-45
13. King CR, Kraus MH, Aaronson SA (1985) Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229: 974-976
14. Konigshoff M, Wilhelm J, Bohle RM, Pingoud A, Hahn M (2003) HER-2/neu gene copy number quantified by real-time PCR: comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue. Clin Chem 49: 219-229
15. Mitchell MS, Press MF (1999) The role of immunohistochemistry and fluorescence in situ hybridization for HER2/neu in assessing the prognosis of breast cancer. Semin Oncol 26: 108-116
16. Mrhalová M, Kodet R, Strnad P (2001) Correlation of c-erbB-2 gene expression (detected by FISH) with membrane expression of erbB-2 protein (detected by IHC) in patients with primary breast carcinomas. Cas Lek Ces 140: 553-559
17. Muleris M, Almeida A, Malfoy B, Dutrillaux B (1997) Assignment of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) to human chromosome band 17q21.1 by in situ hybridization. Cytogenet Cell Genet 76: 34-35
18. Ooi A, Kobayashi M, Mai M, Nakanishi I (1998) Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization. Lab Invest 78: 345-351
19. Perez EA, Roche PC, Jenkins RB, Reynolds CA, Halling KC, Ingle JN, Wold LE (2002) HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization. Mayo Clin Proc 77: 148-154
20. Popescu NC, King CR, Kraus MH (1989) Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32. Genomics 4: 362-366
21. Ratcliffe N, Wells W, Wheeler K, Memoli V (1997) The combination of in situ hybridization and immunohistochemical analysis: an evaluation of Her2/neu expression in paraffin-embedded breast carcinomas and adjacent normal-appearing breast epithelium. Mod Pathol 10: 1247-1252
22. Revillion F, Hornez L, Peyrat JP (1997) Quantification of c-erbB-2 gene expression in breast cancer by competitive RT-PCR. Clin Chem 43: 2114-2120
23. Ridolfi RL, Jamehdor MR, Arber JM (2000) HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach. Mod Pathol 13: 866-873
24. Sauter G, Feichter G, Torhorst J, Moch H, Novotna H, Wagner U, Durmuller U, Waldman FM (1996) Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies. Acta Cytol 40: 164-173
25. Savinainen KJ, Saramaki OR, Linja MJ, Bratt O, Tammela TL, Isola JJ, Visakorpi T (2002) Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer. Am J Pathol 160: 339-345
26. Semba K, Kamata N, Toyoshima K, Yamamoto T (1985) A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci U S A 82: 6497-6501
27. Shih C, Padhy LC, Murray M, Weinberg RA (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261-264
28. Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Francke U, Ullrich A, Coussens L (1985) The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229: 976-978
29. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182
30. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712
31. Tubbs RR, Pettay J, Roche P, Stoler MH, Jenkins R, Myles J, Grogan T (2000) Concomitant oncoprotein detection with fluorescence in situ hybridization (COD-FISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression. J Mol Diagn 2: 78-83
32. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319: 230-234
33. Yokota J, Yamamoto T, Toyoshima K, Terada M, Sugimura T, Battifora H, Cline MJ (1986) Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1: 765-767
34. Zhou D, Battifora H, Yokota J, Yamamoto T, Cline MJ (1987) Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res 47: 6123-6125